206 related articles for article (PubMed ID: 20833643)
1. Anti-citrullinated peptide antibody-negative RA is a genetically distinct subset: a definitive study using only bone-erosive ACPA-negative rheumatoid arthritis.
Ohmura K; Terao C; Maruya E; Katayama M; Matoba K; Shimada K; Murasawa A; Honjo S; Takasugi K; Tohma S; Matsuo K; Tajima K; Yukawa N; Kawabata D; Nojima T; Fujii T; Yamada R; Saji H; Matsuda F; Mimori T
Rheumatology (Oxford); 2010 Dec; 49(12):2298-304. PubMed ID: 20833643
[TBL] [Abstract][Full Text] [Related]
2. Opposing effects of HLA-DRB1*13 alleles on the risk of developing anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis.
Lundström E; Källberg H; Smolnikova M; Ding B; Rönnelid J; Alfredsson L; Klareskog L; Padyukov L
Arthritis Rheum; 2009 Apr; 60(4):924-30. PubMed ID: 19333936
[TBL] [Abstract][Full Text] [Related]
3. Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis.
van der Woude D; Houwing-Duistermaat JJ; Toes RE; Huizinga TW; Thomson W; Worthington J; van der Helm-van Mil AH; de Vries RR
Arthritis Rheum; 2009 Apr; 60(4):916-23. PubMed ID: 19333951
[TBL] [Abstract][Full Text] [Related]
4. ACPA-negative RA consists of two genetically distinct subsets based on RF positivity in Japanese.
Terao C; Ohmura K; Ikari K; Kochi Y; Maruya E; Katayama M; Yurugi K; Shimada K; Murasawa A; Honjo S; Takasugi K; Matsuo K; Tajima K; Suzuki A; Yamamoto K; Momohara S; Yamanaka H; Yamada R; Saji H; Matsuda F; Mimori T
PLoS One; 2012; 7(7):e40067. PubMed ID: 22792215
[TBL] [Abstract][Full Text] [Related]
5. Influence of HLA DRB1 alleles in the susceptibility of rheumatoid arthritis and the regulation of antibodies against citrullinated proteins and rheumatoid factor.
Balsa A; Cabezón A; Orozco G; Cobo T; Miranda-Carus E; López-Nevot MA; Vicario JL; Martín-Mola E; Martín J; Pascual-Salcedo D
Arthritis Res Ther; 2010; 12(2):R62. PubMed ID: 20370905
[TBL] [Abstract][Full Text] [Related]
6. Very high levels of anti-citrullinated protein antibodies are associated with HLA-DRB1*15 non-shared epitope allele in patients with rheumatoid arthritis.
Laki J; Lundström E; Snir O; Rönnelid J; Ganji I; Catrina AI; Bengtsson C; Saevarsdottir S; Wick MC; Alfredsson L; Klareskog L; Padyukov L
Arthritis Rheum; 2012 Jul; 64(7):2078-84. PubMed ID: 22307773
[TBL] [Abstract][Full Text] [Related]
7. Smoking, the HLA-DRB1 shared epitope and ACPA fine-specificity in Koreans with rheumatoid arthritis: evidence for more than one pathogenic pathway linking smoking to disease.
Fisher BA; Bang SY; Chowdhury M; Lee HS; Kim JH; Charles P; Venables P; Bae SC
Ann Rheum Dis; 2014 Apr; 73(4):741-7. PubMed ID: 23505239
[TBL] [Abstract][Full Text] [Related]
8. [Is rheumatoid arthritis without anti-citrullinated peptide antibody a genetically distinct subset?].
Ohmura K
Nihon Rinsho Meneki Gakkai Kaishi; 2009 Dec; 32(6):484-91. PubMed ID: 20046016
[TBL] [Abstract][Full Text] [Related]
9. Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anti-cyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case control study.
Bang SY; Han TU; Choi CB; Sung YK; Bae SC; Kang C
Arthritis Res Ther; 2010; 12(3):R115. PubMed ID: 20537173
[TBL] [Abstract][Full Text] [Related]
10.
Hiwa R; Ikari K; Ohmura K; Nakabo S; Matsuo K; Saji H; Yurugi K; Miura Y; Maekawa T; Taniguchi A; Yamanaka H; Matsuda F; Mimori T; Terao C
J Rheumatol; 2018 Apr; 45(4):470-480. PubMed ID: 29419463
[TBL] [Abstract][Full Text] [Related]
11. Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB1*1301: a meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in four European populations.
van der Woude D; Lie BA; Lundström E; Balsa A; Feitsma AL; Houwing-Duistermaat JJ; Verduijn W; Nordang GB; Alfredsson L; Klareskog L; Pascual-Salcedo D; Gonzalez-Gay MA; Lopez-Nevot MA; Valero F; Roep BO; Huizinga TW; Kvien TK; Martín J; Padyukov L; de Vries RR; Toes RE
Arthritis Rheum; 2010 May; 62(5):1236-45. PubMed ID: 20131291
[TBL] [Abstract][Full Text] [Related]
12. How RA Associated HLA-DR Molecules Contribute to the Development of Antibodies to Citrullinated Proteins: The Hapten Carrier Model.
Roudier J; Balandraud N; Auger I
Front Immunol; 2022; 13():930112. PubMed ID: 35774784
[TBL] [Abstract][Full Text] [Related]
13. Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies.
Jiang X; Trouw LA; van Wesemael TJ; Shi J; Bengtsson C; Källberg H; Malmström V; Israelsson L; Hreggvidsdottir H; Verduijn W; Klareskog L; Alfredsson L; Huizinga TW; Toes RE; Lundberg K; van der Woude D
Ann Rheum Dis; 2014 Oct; 73(10):1761-8. PubMed ID: 24812286
[TBL] [Abstract][Full Text] [Related]
14. Presence of autoantibodies in "seronegative" rheumatoid arthritis associates with classical risk factors and high disease activity.
Reed E; Hedström AK; Hansson M; Mathsson-Alm L; Brynedal B; Saevarsdottir S; Cornillet M; Jakobsson PJ; Holmdahl R; Skriner K; Serre G; Alfredsson L; Rönnelid J; Lundberg K
Arthritis Res Ther; 2020 Jul; 22(1):170. PubMed ID: 32678001
[TBL] [Abstract][Full Text] [Related]
15. Only rheumatoid factor-positive subset of anti-citrullinated peptide/protein antibody-negative rheumatoid arthritis may seroconvert to anti-citrullinated peptide/protein antibody-positive.
Hiwa R; Ohmura K; Nakabo S; Terao C; Murakami K; Nakashima R; Imura Y; Yukawa N; Yoshifuji H; Hashimoto M; Furu M; Ito H; Fujii T; Mimori T
Int J Rheum Dis; 2017 Jun; 20(6):731-736. PubMed ID: 28198158
[TBL] [Abstract][Full Text] [Related]
16. HLA shared epitope and ACPA: just a marker or an active player?
Pratesi F; Petit Teixeira E; Sidney J; Michou L; Puxeddu I; Sette A; Cornelis F; Migliorini P
Autoimmun Rev; 2013 Oct; 12(12):1182-7. PubMed ID: 23958703
[TBL] [Abstract][Full Text] [Related]
17. Anti-citrullinated peptide autoantibodies, human leukocyte antigen shared epitope and risk of future rheumatoid arthritis: a nested case-control study.
Arkema EV; Goldstein BL; Robinson W; Sokolove J; Wagner CA; Malspeis S; Rosner B; Grodstein F; Karlson EW; Costenbader KH
Arthritis Res Ther; 2013 Oct; 15(5):R159. PubMed ID: 24286474
[TBL] [Abstract][Full Text] [Related]
18. A spectrum of susceptibility to rheumatoid arthritis within HLA-DRB1: stratification by autoantibody status in a large UK population.
Mackie SL; Taylor JC; Martin SG; ; ; Wordsworth P; Steer S; Wilson AG; Worthington J; Emery P; Barrett JH; Morgan AW
Genes Immun; 2012 Feb; 13(2):120-8. PubMed ID: 21881596
[TBL] [Abstract][Full Text] [Related]
19. Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status.
Bang SY; Lee KH; Cho SK; Lee HS; Lee KW; Bae SC
Arthritis Rheum; 2010 Feb; 62(2):369-77. PubMed ID: 20112396
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to porphyromonas gingivalis are associated with anticitrullinated protein antibodies in patients with rheumatoid arthritis and their relatives.
Hitchon CA; Chandad F; Ferucci ED; Willemze A; Ioan-Facsinay A; van der Woude D; Markland J; Robinson D; Elias B; Newkirk M; Toes RM; Huizinga TW; El-Gabalawy HS
J Rheumatol; 2010 Jun; 37(6):1105-12. PubMed ID: 20436074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
